SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011836
Filing Date
2021-05-17
Accepted
2021-05-17 16:06:28
Documents
87
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 620813
2 ex31.htm EX-31 33840
3 ex32.htm EX-32 8531
  Complete submission text file 0001493152-21-011836.txt   5387189

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ocx-20210331.xml EX-101.INS 890734
5 XBRL SCHEMA FILE ocx-20210331.xsd EX-101.SCH 76298
6 XBRL CALCULATION FILE ocx-20210331_cal.xml EX-101.CAL 100314
7 XBRL DEFINITION FILE ocx-20210331_def.xml EX-101.DEF 267686
8 XBRL LABEL FILE ocx-20210331_lab.xml EX-101.LAB 492591
9 XBRL PRESENTATION FILE ocx-20210331_pre.xml EX-101.PRE 395808
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 21930448
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences